Evaluating Pharmacokinetics and Pharmacodynamics of Jusline
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Drug: Jusline
- Registration Number
- NCT00532766
- Lead Sponsor
- King Saud University
- Brief Summary
To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration, and to compare this profile with Humulin insulin.
- Detailed Description
To study the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration in the abdominal, and to compare this profile with Humulin insulin for three different preparations (Regular, NPH, and Premixed Regular/NPH (30/70)).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
- Healthy
- Non-diabetic
- Age 18-35 year
- Normal body mass index (BMI 18-25 kg/m2)
Exclusion Criteria
- Diabetics
- Overweight/obese
- Anemic, with liver, cardiac, renal or thyroid dysfunction
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description 2 Jusline Jusline Humulin
- Primary Outcome Measures
Name Time Method To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Diabetes Center
🇸🇦Riyadh, Saudi Arabia